Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: guarantee (67), certify (28), warrant (16)

Bendamustine_70_RituximabSplit

Description: Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA BENDAMUSTINE (70)-RITUXIMAB (Split) This protocol may require funding There
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Bendamustine-70-RituximabSplit.pdf

Bendamustine_70_Rituximab

Description: Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA BENDAMUSTINE (70)-RITUXIMAB There are multiple versions of this protocol in use that
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Bendamustine-70-Rituximab.pdf

Procedure for adult circumference measurements

Description: NIHR Southampton Biomedical Research Centre The NIHR Southampton Biomedical Research Centre (BRC) has a tight quality assurance system for the writin
Url: /Media/Southampton-Clinical-Research/Procedures/BRCProcedures/Procedure-for-adult-circumference-measurements.pdf

SOP for identifying SAEs within POSCUs - 1 February 2013

Description: Paediatric Oncology UHSStandard Operating ProcedureIdentification of Serious Adverse Events occurring in Paediatric Oncology Shared Care Units linked to the University Hospital
Url: /Media/UHS-website-2019/Docs/PaediatricOncology/POSCU/SOP-for-identifying-SAEs-within-POSCUs-01-02-2013.pdf

Aria ePrescribing v13.6 MR1.2 user training guide

Description: Aria E-Prescribing v13.6 MR1.2 User Training Guide Every effort has been made to ensure that the material in
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/User-guides/Aria-ePrescribing-v13.6-MR1.2-user-training-guide.pdf

Wessex Diabetes Network - Individual health care plan - Injections

Description: Individual Health Care Plan � Educational Setting FOR PUPILS WITH DIABETES Name: DOB: School: Year Group: Date of Plan: Insert Photo here Review Da
Url: /Media/UHS-website-2019/Docs/Services/Child-health/Diabetes/Wessex-Diabetes-Network-Individual-health-care-plan-Injections.pdf

R&D public engagement and participation strategy

Description: University Hospital Southampton NHS Foundation Trust public engagement and participation strategy Executive summary This strategy outlines th
Url: /Media/Southampton-Clinical-Research/PPI/RD-public-engagement-and-participation-strategy.pdf

Deprivation of liberty in adults and children

Description: Governments encourage patients to believe they have choice, which may extend to the identity of their surgeon. Irrespective of whether this
Url: /HealthProfessionals/Clinical-law-updates/Deprivation-of-liberty-in-adults-and-children.aspx

AmB-LISOCEL-Cyclophosphamide (300)-Fludarabine (30)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY AmB – LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUD
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-LISOCEL-Cyclophosphamide-300-Fludarabine-30.pdf

Carboplatin-Docetaxel-Pertuzumab-Trastuzumab_IV-SC

Description: Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC6)-DOCETAXEL- PERTUZUMABTRASTUZUMAB (IV/SC) Regimen • Breast Cancer – Carboplatin (AUC
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Docetaxel-Pertuzumab-Trastuzumab-IV-SC.pdf

151 to 160 of 1000

Previous … 14 15 16 17 18 … Next